跳至主要内容
临床试验/NCT05690542
NCT05690542尚未招募不适用

Nanoparticles in Blood: Understanding and Controlling Protein Corona for Optimized Nanomedicine

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年2月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
impact of nanoparticles on coagulation tests ou platelet functions

研究概览

简要总结

The main objective is to study the effect of engineered nanoparticles SPIONs (superparamagnetic iron oxide) on hemostasis. Nanoparticles will be incubated in blood and platelet aggregation will be measured. In parallel, nanoparticles will also be incubated in blood and then plasma proteins adsorbed on them will be separated and analyzed. The proteins found on the nanoparticles will be linked to the platelet aggregation observed to help developing innovative protein functionalized nanoprobes for optimized nanomedicine.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • all people

排除标准

  • patient under 18 years old, legal protection measure, pregnancy

结局指标

主要结局

impact of nanoparticles on coagulation tests ou platelet functions

时间窗: at the baseline

次要结局

  • Difference of behaviour of the nanoparticles (N=10 preparations) on coagulation cascade and platelet functions(at the baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验